Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 21 of 21 entries
View as:

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01666119 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT03720613 Org: User:
Start: 01/04/19 End: 11/01/30 Due: 11/01/31

Efficacy, Tolerability, and Safety of DFN-15

Phase: N/A Priority: Normal
NCT ID: NCT03009019 Org: User:
Start: 12/31/16 End: 05/31/19 Due: 05/31/20

Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00293020 Org: User:
Start: 02/28/06 End: 06/30/08 Due: 06/30/09

Long-term Extension Study of BEMA™ Fentanyl

Phase: N/A Priority: Normal
NCT ID: NCT00696137 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02068027 Org: User:
Start: 03/31/14 End: 03/31/15 Due: 03/31/16

The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02643251 Org: User:
Start: 12/31/15 End: 11/30/16 Due: 11/30/17

Long-term Open-Label Safety Study to Evaluate EN3409

Phase: N/A Priority: Normal
NCT ID: NCT01755546 Org: User:
Start: 12/31/12 End: 11/30/14 Due: 11/30/15

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01633944 Org: User:
Start: 08/31/12 End: 12/31/13 Due: 12/31/14

Efficacy, Tolerability, and Safety Study of DFN-15

Phase: N/A Priority: Normal
NCT ID: NCT03006276 Org: User:
Start: 12/31/16 End: 05/31/19 Due: 05/31/20

Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

Phase: N/A Priority: Normal
NCT ID: NCT03996694 Org: User:
Start: 07/23/19 End: 10/27/19 Due: 10/27/20

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01675167 Org: User:
Start: 09/30/12 End: 06/30/14 Due: 06/30/15

Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01256450 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

Phase: N/A Priority: Normal
NCT ID: NCT01871285 Org: User:
Start: 06/30/13 End: 07/31/14 Due: 07/31/15

A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02355158 Org: User:
Start: 06/30/14 End: 09/30/15 Due: 09/30/16

Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT00941304 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01431742 Org: User:
Start: 07/31/12 End: 07/31/13 Due: 07/31/14

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02516436 Org: User:
Start: - End: 05/01/17 Due: 05/01/18

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01298765 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00293033 Org: User:
Start: 02/28/06 End: 04/30/07 Due: 04/30/08

Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01713803 Org: User:
Start: - End: 05/01/17 Due: 05/01/18